|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||88.42 - 90.61|
|52-week range||76.45 - 106.66|
|Beta (5Y monthly)||0.43|
|PE ratio (TTM)||17.39|
|Earnings date||03 Feb 2023|
|Forward dividend & yield||3.33 (3.71%)|
|Ex-dividend date||06 May 2022|
|1y target est||102.70|
Expedia, IDEXX Laboratories, Tradeweb Markets, SolarEdge Technologies and Sanofi are included in this Analyst Blog.
A federal appeals court rejects J&J's (JNJ) efforts to shift over 38,000 lawsuits related to its talcum-based baby powder out of trial courts and into bankruptcy court.
(Bloomberg) -- Haleon Plc, the consumer health business spun out from British pharmaceutical producer GSK Plc, is in the early stages of studying large potential deals to bulk up its brand portfolio, people with knowledge of the matter said. Most Read from BloombergSony Slashes PlayStation VR2 Headset Output After Pre-Orders DisappointPutin’s War in Ukraine Pushes Ex-Soviet States Toward New AlliesBrexit Is Costing the UK £100 Billion a Year in Lost OutputTrump Sues Journalist Bob Woodward for R